SpineCraft was granted FDA 510(k) clearance to market the ORIO-3D Interbody Platform, a comprehensive portfolio of trabecular 3D-printed titanium implants to support spinal fusion for various surgical approaches.
The ORIO-3D Trabecular design represents a significant step forward in fusion technology. Implants are engineered with a biomimetic pore structure intended to promote osseointegration & early biologic fixation, and incorporate a unique architecture designed for low stiffness and optimal distribution of mechanical loads across the vertebral endplates.
By promoting more uniform load sharing and with the added benefit of lower stiffness, implants in the ORIO-3D platform are intended to help mitigate potential subsidence risk and support the maintenance of intervertebral height and segmental alignment.
SpineCraft was granted FDA 510(k) clearance to market the ORIO-3D Interbody Platform, a comprehensive portfolio of trabecular 3D-printed titanium implants to support spinal fusion for various surgical approaches.
The ORIO-3D Trabecular design represents a significant step forward in fusion technology. Implants are engineered with a biomimetic...
SpineCraft was granted FDA 510(k) clearance to market the ORIO-3D Interbody Platform, a comprehensive portfolio of trabecular 3D-printed titanium implants to support spinal fusion for various surgical approaches.
The ORIO-3D Trabecular design represents a significant step forward in fusion technology. Implants are engineered with a biomimetic pore structure intended to promote osseointegration & early biologic fixation, and incorporate a unique architecture designed for low stiffness and optimal distribution of mechanical loads across the vertebral endplates.
By promoting more uniform load sharing and with the added benefit of lower stiffness, implants in the ORIO-3D platform are intended to help mitigate potential subsidence risk and support the maintenance of intervertebral height and segmental alignment.
Copy to clipboard 
